Literature DB >> 17609689

The fallacy of the calcium-phosphorus product.

W C O'Neill1.   

Abstract

Scattered through the practice of medicine are dogmas with little or no scientific basis. One of these is the product of the serum calcium and phosphorus concentrations, the so-called calcium-phosphorus product or Ca x P. The assumption that ectopic calcification will occur when the product of the serum calcium and phosphorus concentrations exceeds a particular threshold has become standard practice in nephrology even though there is little scientific basis. Experimental support is lacking, the chemistry underlying the use of the product is oversimplified and the concept that ectopic calcification is simply the result of supersaturation is biologically flawed. The evidence that the Ca x P is an independent risk factor for mortality and morbidity is also questionable. Although ectopic calcification can occur in many sites, this review will focus on vascular calcification, as it is the most common site and the site most likely to affect patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17609689     DOI: 10.1038/sj.ki.5002412

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  41 in total

Review 1.  Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.

Authors:  Noam Eliaz; Noah Metoki
Journal:  Materials (Basel)       Date:  2017-03-24       Impact factor: 3.623

2.  Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.

Authors:  Karen K Winer; Andrea Kelly; Alicia Johns; Bo Zhang; Karen Dowdy; Lauren Kim; James C Reynolds; Paul S Albert; Gordon B Cutler
Journal:  J Pediatr       Date:  2018-12       Impact factor: 4.406

3.  Mineral metabolism disturbances are associated with the presence and severity of calcific aortic valve disease.

Authors:  Zhen-kun Yang; Chen Ying; Hong-yan Zhao; Yue-hua Fang; Ying Chen; Wei-feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

4.  Supersaturation of body fluids, plasma and urine, with respect to biological hydroxyapatite.

Authors:  Otakar Söhnel; Felix Grases
Journal:  Urol Res       Date:  2011-05-14

5.  Calcium orthophosphates (CaPO4): occurrence and properties.

Authors:  Sergey V Dorozhkin
Journal:  Prog Biomater       Date:  2015-11-19

6.  Association of serum inorganic phosphate with sex steroid hormones and vitamin D in a nationally representative sample of men.

Authors:  W Wulaningsih; M Van Hemelrijck; K Michaelsson; N Kanarek; W G Nelson; J H Ix; E A Platz; S Rohrmann
Journal:  Andrology       Date:  2014-10-01       Impact factor: 3.842

7.  Phosphate levels and blood pressure in incident hemodialysis patients: a longitudinal study.

Authors:  Cindy Xin Huang; Laura C Plantinga; Nancy E Fink; Michal L Melamed; Josef Coresh; Neil R Powe
Journal:  Adv Chronic Kidney Dis       Date:  2008-07       Impact factor: 3.620

8.  Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification.

Authors:  K A Lomashvili; P Garg; S Narisawa; J L Millan; W C O'Neill
Journal:  Kidney Int       Date:  2008-02-20       Impact factor: 10.612

9.  Plasma pyrophosphate and vascular calcification in chronic kidney disease.

Authors:  W Charles O'Neill; Mhairi K Sigrist; Christopher W McIntyre
Journal:  Nephrol Dial Transplant       Date:  2009-07-24       Impact factor: 5.992

Review 10.  Kidney disease outcomes quality initiative guidelines for bone and mineral metabolism: emerging questions.

Authors:  Tejas V Patel; Ajay K Singh
Journal:  Semin Nephrol       Date:  2009-03       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.